HIV/AIDS Clinical Trials in Chicago

Showing 381-400 of 648 trials

Assessing the Engagement of Transgender and Other Gender Minority Youth Across the HIV Continuum of Care

NCT02449629

This study uses a transformative multiphasic mixed-methods research design that incorporates elements of the following designs: * Sequential: a secondary data analysis was conducted, using data from ATN 039, ATN 086, and ATN 106, to influence the development of the qualitative interview and quantitative survey instruments for primary data collection. * Convergent parallel: concurrent collection and analysis of both qualitative and quantitative primary data that will be combined to address the study objectives.

Transgender, HIV Continuum of Care

University of North Carolina, Chapel Hill187 participantsStarted Jun 2015

Los Angeles, California, United States • Aurora, Colorado, United States • Washington D.C., District of Columbia, United States +11 more locations

COMPLETED2.2 miles

Treatment De-Intensification and Residual HIV-1 in Youth

NCT00867854

This laboratory-based sub-study of ATN 061 and ATN 071 will examine the effect of early treatment followed by treatment de-intensification to atazanavir/ritonavir (ATV/r) monotherapy on steady-state frequencies of replication-competent CD4+ T cell Human Immunodeficiency Virus (HIV)-1 reservoirs or cell-associated infectivity (CAI) and persistent low-level viremia (LLV), and their contribution to successful long-term control of HIV-1 replication among HIV-1 infected adolescents and young adults.

HIV-1HIV Infections

University of North Carolina, Chapel Hill34 participantsStarted Feb 2009

Los Angeles, California, United States • San Francisco, California, United States • Washington D.C., District of Columbia, United States +14 more locations

Assessing the Engagement of Transgender and Other Gender Minority Youth Across the HIV Continuum of Care

Treatment De-Intensification and Residual HIV-1 in Youth

HIV/AIDS Trials in Other Cities

HIV Treatment-Readiness Measure (HTRM) Validation

Evaluation of Genetic Markers as Explanations for the Observed Differences in Disease Progression in HIV+ Youth

C2P Mobilization Intervention (Pilot)

PK of Once Daily ART Containing Tenofovir and Atazanavir/Ritonavir

Intervention Development for Newly Diagnosed Youth With HIV

ID and Testing Via Friendship Networks

Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV

Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection

A Study of HIV in Newly Infected Individuals

The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood

Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials

Expanded Access Program for Maraviroc At Multiple Centers

Collection of Samples From HIV-1 Infected Individuals for Evaluation of the Aptima HIV-1 Assay

Correlates of Oral Human Papillomavirus Infection in Adolescents and Young Adults With Behaviorally Acquired HIV

A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients

An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.

BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1.

Use of Muscle Spectroscopy to Evaluate Mitochondrial Dysfunction in HIV-Infected Patients

Other Conditions in Chicago